Pulse Biosciences CS (PLSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 444 | 844 | 574 | 0 | 0 |
| Cost of Goods | 909 | 1,241 | 727 | N/A | N/A |
| Gross Profit | -465 | -397 | -153 | N/A | N/A |
| Operating Expenses | 17,717 | 15,254 | 14,847 | 14,806 | 18,525 |
| Operating Income | -17,273 | -15,410 | -14,273 | -14,806 | -18,525 |
| Other Income | 0 | -6 | -9 | -517 | -114 |
| Pre-tax Income | -17,273 | -15,416 | -14,282 | -15,323 | -18,639 |
| Net Income Continuous | -17,273 | -15,416 | -14,282 | -15,323 | -18,639 |
| Net Income | $-17,273 | $-15,416 | $-14,282 | $-15,323 | $-18,639 |
| EPS Basic Total Ops | -0.58 | -0.51 | -0.48 | -0.58 | -0.71 |
| EPS Basic Continuous Ops | -0.58 | -0.50 | -0.48 | -0.58 | -0.71 |
| EPS Diluted Total Ops | -0.58 | -0.51 | -0.48 | -0.58 | -0.71 |
| EPS Diluted Continuous Ops | -0.58 | -0.50 | -0.48 | -0.58 | -0.71 |
| EBITDA(a) | $-16,947 | $-15,113 | $-13,986 | $-14,524 | $-18,232 |